Valuation Carvolix Börse Stuttgart
Stocks
0JZ
FR0013333077
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.500 EUR | +0.36% |
|
+4.58% | +246.84% |
| 07-06 | Carvolix Presents Clinical Data on TAVIPILOT Platform At New York Valves 2026 | CI |
| 06-24 | French Medical Technology Company Carvolix Plans EUR10 Million Share Offering | MT |
Company Valuation: Carvolix
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 32.61 | 63.01 | 55 | 373.3 | 373.3 | - |
| Change | - | 93.22% | -12.73% | 578.87% | 0% | - |
| Enterprise Value (EV) 1 | 32.61 | 80 | 71.4 | 401.2 | 424.4 | 459.2 |
| Change | - | 145.32% | -10.76% | 461.85% | 5.79% | 8.21% |
| P/E | - | -3.42x | -3.29x | -12.6x | -11.8x | -11.2x |
| PBR | - | 1.81x | 1.75x | 12.2x | 66.6x | -22.2x |
| PEG | - | - | 0.1x | -1.57x | -1.68x | -2.02x |
| Capitalization / Revenue | - | - | 11.8x | - | 260x | 38x |
| EV / Revenue | - | - | 15.3x | - | 296x | 46.7x |
| EV / EBITDA | - | -5.75x | -5.14x | -24x | -13.6x | -13.8x |
| EV / EBIT | - | -4.85x | -4.3x | -19.8x | -12.5x | -12.8x |
| EV / FCF | - | -6.1x | -5.49x | -21.2x | -10.9x | -11.4x |
| FCF Yield | - | -16.4% | -18.2% | -4.72% | -9.13% | -8.8% |
| Dividend per Share 3 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 3 | - | -0.54 | -0.41 | -0.4429 | -0.4739 | -0.5003 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | 4.669 | - | 1.435 | 9.834 |
| EBITDA 1 | - | -13.91 | -13.9 | -17.16 | -31.17 | -33.22 |
| EBIT 1 | - | -16.49 | -16.62 | -19.68 | -33.98 | -35.78 |
| Net income 1 | -16.61 | -16.77 | -16.74 | -28.8 | -33.13 | -34.68 |
| Net Debt 1 | - | 16.99 | 16.4 | 27.81 | 51.04 | 85.89 |
| Reference price 3 | 1.680 | 1.845 | 1.350 | 5.600 | 5.600 | 5.600 |
| Nbr of stocks (in thousands) | 18,164 | 30,899 | 39,348 | 59,244 | 59,244 | - |
| Announcement Date | 3/30/23 | 4/25/24 | 4/24/25 | 3/19/26 | - | - |
1EUR in Million2USD in Million3EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 63.45x | 7.56x | 40.56x | -.--% | 12.57B | |
| 20.41x | 2.03x | 10.14x | 2.24% | 6.45B | |
| 29.96x | 6.2x | 16.8x | 1.27% | 5.75B | |
| 27.08x | 1.33x | 8.31x | -.--% | 4.96B | |
| 29x | 8.63x | 21.95x | 0.69% | 4.35B | |
| 17.35x | 3.05x | 14.55x | 3.76% | 3.98B | |
| -13.55x | 2.47x | -14.5x | - | 1.98B | |
| -16.71x | 415.05x | -72.07x | -.--% | 1.72B | |
| 21.15x | 2.53x | 10.25x | 2.05% | 1.62B | |
| Average | 19.79x | 49.87x | 4.00x | 1.25% | 4.82B | |
| Weighted average by Cap. | 32.49x | 21.24x | 16.84x | 1.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CVX Stock
- 0JZ Stock
- Valuation Carvolix
Select your edition
All financial news and data tailored to specific country editions
